Cachexia is a serious yet under-recognized consequence of many chronic diseases, including heart disease, kidney disease, chronic obstructive pulmonary disease and, most notably, cancer.

View Full Profile. Learn about our Editorial Policies. Towards the final stages of diseases such as cancer and kidney disease, many patients develop cachexia, a devastating condition in which muscle ...

Historically, cachexia has not been fully understood. Also known as wasting syndrome, cachexia is often incorrectly viewed as simply an inevitable side effect to cancer and other chronic conditions.

Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with advanced cancer. A new ...

The experimental drug ponsegromab is a monoclonal antibody that treats the growth factor that leads to the growth of cancer ...

Weight-loss medication has taken the world by storm and helped many overweight people. But for some, significant weight loss ...

Cardiac cachexia is the weight loss and decrease in appetite that occurs during states of chronically low cardiac output and congestive heart failure. This gives a poor prognosis independent of ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600, ...

A $3.2 million grant from @NIH is empowering @UHouston researchers to tackle Rhabdomyosarcoma, a malignant cancer that has a ...

Kairos Pharma (KAPA) announced that through its academic partnership with Cedars-Sinai Medical Center, Cedars-Sinai has received $600,000 in ...